Shimokawa Kenichiro | Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd.
スポンサーリンク
概要
- Shimokawa Kenichiroの詳細を見る
- 同名の論文著者
- Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd.の論文著者
Pharmaceutical Research Division, Takeda Pharmaceutical Co., Ltd. | 論文
- The Chondroprotective Agent ITZ-1 Inhibits Interleukin-1β-Induced Matrix Metalloproteinase-13 Production and Suppresses Nitric Oxide-Induced Chondrocyte Death
- Potent NK_1 Receptor Antagonists : Synthesis and Antagonistic Activity of Various Heterocycles with an N-[3,5-Bis(trifluoromethyl)benzyl]-N-methylcarbamoyl Substituent
- A New Chondrogenic Differentiation Initiator With the Ability to Up-Regulate SOX Trio Expression
- Discovery of a Potent and Orally Available Acyl-CoA: Cholesterol Acyltransferase Inhibitor as an Anti-atherosclerotic Agent: (4-Phenylcoumarin)acetanilide Derivatives
- Discovery of a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor: The Synthesis, Biological Evaluation, and Reduced Adrenal Toxicity of (4-Phenylcoumarin)acetanilide Derivatives with a Carboxylic Acid Moiety